Stephen Hoffman will become the CEO of Aerpio Pharmaceuticals Inc. on Dec. 1.
Hoffman succeeds Joseph Gardner, the founder of the company, who will continue to serve as president.
Hoffman joins the company from PDL BioPharma Inc., an investment firm.